Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Myfortic Regimens in De Novo Kidney Transplant
NCT00101738Phase 3Completed
- Sponsor
- Novartis
- Start
- Mar 2003
- Primary completion
- May 2005
- Modality
- Small Molecules
- Countries
- 13
01
Overview
A Phase 3 trial of mycophenolate sodium in kidney transplantation, sponsored by Novartis. Started Mar 2003; status: completed.
02
Drugs
mycophenolate sodium
03
Conditions
kidney transplantation
Beyond the preview
Go deeper on NCT00101738.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00101738.